Effects of Perinatal Nicotine Exposure on Development of [^3H]Hemicholinium-3 Binding Sites in Rat Neonate Brain

Access this Article

Author(s)

Abstract

In this study, [<SUP>3</SUP>H]hemicholinium−3([<SUP>3</SUP>H]HC−3)binding, which labels the presynaptic high affinity−choline transport sites, was examined in two brain regions, cerebral cortex and midbrain, of nicotine−treated and −untreated rat neonates.In nicotine−untreated neonates, [<SUP>3</SUP>H]HC−3 binding sites of cerebral cortex increased from 64 fmol/mg protein at postnatal day 7 to 142 fmol/mg protein at postnatal day 35.In nicotine−treated neonates, the development of [<SUP>3</SUP>H]HC−3 binding sites in cerebral cortex was significantly retarded, compared with control neonates on the 7th, 14th and 21st postnatal days.In parallel with this, the development of muscarinic receptor in cerebral cortex, which was detected by [<SUP>3</SUP>H]quinuclidinyl benzylate([<SUP>3</SUP>H]QNB)binding, was also retarded by nicotine treatment.However, in midbrain, neither [<SUP>3</SUP>H]HC−3 nor [<SUP>3</SUP>H]QNB binding sites at postnatal day 14 was affected by nicotine treatment.These results strongly suggest that perinatal treatment with nicotine inhibits presynaptic and postsynaptic development of the cholinergic pathway in cerebral cortex but not in midbrain of rat neonate.

Journal

  • The Japanese Journal of Pharmacology

    The Japanese Journal of Pharmacology 84(1), 32-35, 2000-09-01

    The Japanese Pharmacological Society

References:  16

Codes

  • NII Article ID (NAID)
    10008185048
  • NII NACSIS-CAT ID (NCID)
    AA00691188
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    00215198
  • NDL Article ID
    5526053
  • NDL Source Classification
    ZS51(科学技術--薬学)
  • NDL Call No.
    Z53-D199
  • Data Source
    CJP  NDL  J-STAGE 
Page Top